Autopsy report · NCT06207331

Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease

“no patient enrolled.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 8 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

The Second Affiliated Hospital of Chongqing Medical University

Sponsor type

University, hospital or other

Conditions

Respiratory Function Tests; Chronic Obstructive Pulmonary Disease; Dexmedetomidine

Interventions

Dexmedetomidine 0.5 μg/kg; Dexmedetomidine 1 μg/kg; Saline

Participants

6

Sites

1

Countries

China

Trials that died the same way

• Energy Expenditure and Gastric Bypass Surgery
  “no patients enrolled.” (96% match in meaning)
• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
  “No eligible patient was enrolled.” (94% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (94% match in meaning)
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
  “No eligible patients were enrolled.” (92% match in meaning)
• Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain
  “No patients enrolled in the study.” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.